Elsevier

Ophthalmology

Volume 88, Issue 7, July 1981, Pages 583-600
Ophthalmology

Photocoagulation Treatment of Proliferative Diabetic Retinopathy: Clinical Application of Diabetic Retinopathy Study (DRS) Findings, DRS Report Number 8

https://doi.org/10.1016/S0161-6420(81)34978-1Get rights and content

Abstract

Additional follow-up confirms previous reports1–4 from the Diabetic Retinopathy Study (DRS) that photocoagulation, as used in the study, reduces the risk of severe visual loss by 50% or more. Decreases of visual acuity of one or more lines and constriction of peripheral visual field due to treatment were also observed in some eyes. These harmful effects were more frequent and more severe following the DRS xenon technique.3,4 The two-year risk of severe visual loss without treatment outweighs the risk of harmful treatment effects for two groups of eyes: (1) eyes with new vessels and preretinal or vitreous hemorrhage; and (2) eyes with new vessels on or within one disc diameter of the optic disc (NVD) equaling or exceeding 1/4 to 1/3 disc area in extent, (Fig 1), even in the absence of preretinal or vitreous hemorrhage. For eyes with these characteristics, prompt treatment is usually advisable. For eyes with less severe retinopathy, DRS findings do not provide a clear choice between prompt treatment or deferral unless progression to these more severe stages occurs.

References (7)

  • Preliminary Report on Effects of Photocoagulation Therapy

    Am J Ophthalmol

    (1976)
  • Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings

    Ophthalmology

    (1978)
  • The Diabetic Retinopathy Study Research Group. Photocoagulation Treatment of Proliferative Diabetic Retinopathy: A...
There are more references available in the full text version of this article.

Cited by (1104)

  • Endpoints for clinical trials in ophthalmology

    2023, Progress in Retinal and Eye Research
  • Treatment of Proliferative Diabetic Retinopathy in 2023

    2024, International Ophthalmology Clinics
View all citing articles on Scopus

Presented at the Eighty-Fifth Annual Meeting of the American Academy of Ophthalmology, Chicago, November 2–7, 1980.

The DRS is supported by contracts with the National Eye Institute, National Institutes of Health, US Department of Health and Human Services.

View full text